ADAMTS13 Plays a Novel Role in Hyperfibrinolysis After Trauma-Induced Shock
Joshua Muia, Associate Investigator at Versiti Blood Research Institute, reposted from Derek Kleinveld on LinkedIn:
”Thank you Derek Kleinveld for the opportunity to collaborate with my group.”
Quoting Derek Kleinveld‘s post:
”Happy to share our latest publication on a novel role for ADAMTS13 in trauma-induced shock. Thanks to all collaborators!”
Title: A novel role for ADAMTS13 in hyperfibrinolysis after trauma-induced shock
Authors: Pieter H. Sloos, Lisa Vermeersch, Daphne S. Roozendaal, Anne-Sophie Delmote, Cornelis van ‘t Veer, Thomas O. Momanyi, Frida Z. Miranda, Joshua Muia, Claudia Tersteeg, Karen Vanhoorelbeke, Nicole P. Juffermans, Derek J.B. Kleinveld
Read the full article here.
Stay updated on the latest scientific advancements with Hemostasis Today.
-
Jan 30, 2026, 10:34Saif ur Rahman Compares K2 and K3 EDTA: Key Differences Explained
-
Jan 30, 2026, 10:22Manpreet Gill on Heparin Resistance: When 14 Years of Experience Finally Gets a Plot Twist
-
Jan 30, 2026, 10:14Mohamed Elsaid on The Role of Hyperlipidemia in Thrombogenesis
-
Jan 30, 2026, 09:57From Risk Visualization to Plaque Change: Babak Alex Vakili on CAC and CCTA Insights
-
Jan 29, 2026, 14:02Emma Lefrancais on Alarmin IL33 and Platelet Biology
-
Jan 29, 2026, 13:44Sia A: One of My Favorite Conversations from ASH
-
Jan 29, 2026, 13:34Sarah Matuja on Tanzania Stroke Project
-
Jan 29, 2026, 13:28Nancy Di Salvo on Amplifying Rare Disease Voices Through Partnership
-
Jan 29, 2026, 13:21Raul Santos Shares The Results of ORION-16: On The Efficacy and Safety of Inclisiran